uploads///hemp leaf _

Aurora Cannabis: Analysts’ Ratings and Target Price


May. 16 2019, Published 8:04 a.m. ET

Aurora Cannabis

Aurora Cannabis (ACB) reported its third-quarter earnings on May 14. Since then, the stock has mainly moved sideways. Let’s look at how analysts’ ratings and target price have changed since the earnings release.

Article continues below advertisement

Analysts’ ratings

As of May 15, analysts’ consensus rating on the stock was a “buy. ” Four analysts have a “strong buy” recommendation on the stock—compared to three analysts in the previous period. Currently, six analysts have a “buy” recommendation on the stock—compared to five analysts in the previous period. In May, two analysts maintained a “hold” rating, while one analyst maintained a “sell” rating on the stock.

Canopy Growth (WEED) has an overall “buy” rating in May. HEXO (HEXO) has a consensus “buy” rating, while Tilray (TLRY) has a consensus “hold” rating in May.

Target price

Aurora Cannabis’ current consensus target price was 14.5 Canadian dollars, which increased from 13.8 Canadian dollars in the previous period. The median target price on the stock is 15 Canadian dollars.

Aurora Cannabis closed at 11.7 Canadian dollars on May 15 with a potential upside of 24% from the price convergence. The Horizons Marijuana Life Sciences ETF (HMMJ) closed at 20.2 Canadian dollars with a daily gain of 0.7%.


More From Market Realist

    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.